期刊文献+

肝内胆管细胞癌合并肝门巨大淋巴结转移一例

Intrahepatic Cholangiocarcinoma with Huge Hilar Hepatic Lymph Node Metastasis: A Case Report
下载PDF
导出
摘要 目的:明确肝内胆管细胞癌合并淋巴结转移的患者行淋巴结清扫术的安全性以及可能获益。方法:分析1例原发性肝内胆管细胞癌合并巨大的肝门部淋巴结转移的中老年男性患者的临床表现、影像学表现、手术情况、术后并发症以及随访情况。结果:此例患者手术时间为315分钟,术中出血500 ml,术后住院时间8天,无术后主要并发症,该患者病理为中–低分化胆管细胞癌,肿瘤大小5 ×3.5 ×3 cm,8、12、13组淋巴结转移癌并融合肿块,目前随访8个月未见肿瘤复发。结论:肝内胆管细胞癌合并淋巴结转移的患者行淋巴结清扫术,手术风险可控,可能延长患者的无病生存期。 Objective: To determine the safety and potential benefit of lymph node dissection in patients with intrahepatic cholangiocellular carcinoma with lymph node metastasis. Methods: A case of primary intrahepatic cholangiocarcinoma with large hilar lymph node metastasis was analyzed, including the clinical manifestations, imaging manifestations, surgical status, postoperative complications and follow-up. Results: The operation time of this patient was 315 minutes, the intraoperative hemorrhage was 500 ml, the postoperative hospital stay was 8 days, and no major postoperative complications were observed. The patient was pathologically identified as moderately to poorly differentiated cholangiocarcinoma with tumor size of 5 ×3.5 ×3 cm, lymph node metastasis and mass fusion in group 8, 12, and 13, and no tumor recurrence was observed during 8 months of follow-up. Conclusion: Lymph node dissection in patients with intrahepatic cholangiocellular carcinoma with lymph node metastasis can control the risk of operation and may prolong the disease-free survival of patients.
出处 《亚洲外科手术病例研究》 2021年第3期45-50,共6页 Asian Case Reports in Surgery
  • 相关文献

参考文献2

二级参考文献26

  • 1Aljiffry M, Abdulelah A, Walsh M, et al. Evidence-based ap- proach to cholangiocarcinoma: a systematic review of the current literature [ J ]. J Am Coll Surg,2009,208 ( 1 ) : 134-147. DOI : 10. 1016/j. jamcollsurg. 2008.09. 007.
  • 2Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of in- trahepatic cholangiocarcinoma in the United States: a true in- crease? [J].J Hepatol,2004,40 (3) :472-477. DOI : 10. 1016/ j. jhep. 2003.11. 030.
  • 3Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diag- nosis and management of intrahepatic cholangiocarcinoma [ J ]. J Hepatol,2014,60 (6) : 1268-1289. DOI : 10. 1016/j. jhep. 2014. 01. 021.
  • 4Benson AB, D'Angelica MI, Abrams TA, et al. Hepatobiliary cancers, version 2. 2014[ J]. J Natl Compr Canc Netw,2014,12 (8) :1152-1182.
  • 5Ribero D, Pinna AD, Guglielmi A, et al. Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcino- ma: A Multi-institutional Analysis of 434 Patients [ J ]. Arch Surg, 2012,147 ( 12 ) : 1107-1113. DOI : 10. 1001/archsurg. 2012. 1962.
  • 6Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy [ J ]. J Clin Oncol, 2013,31 (9) : 1188-1195. DOI : 10. 1200/JCO. 2012.41. 5984.
  • 7de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment [ J ]. J Clin Oncol, 2011,29(23 ) :3140-3145. DOI:10. 1200/JCO. 2011.35. 6519.
  • 8Hyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatie cholangiocarcino- ma: an Eastern and Western experience [J]. JAMA Surg,2014, 149 (5) :432-438. DOI : 10. 1001/jamasurg. 2013.5168.
  • 9Spolverato G, Kim Y, Ejaz A, et al. Conditional Probability of Long-term Survival After Liver Resection for Intrahepatic Cholan- giocarcinoma: A Multi-institutional Analysis of 535 Patients [ J ]. JAMA Surg, 2015,150 ( 6 ) : 538-545. DOI: 10. 1001/jamasurg. 2015. 0219.
  • 10Kim Y, Spolverato G, Amini N, et al. Surgical Management of In- trahepatic Cholangiocarcinoma: Defining an Optimal Prognostic Lymph Node Stratification Schema[J]. Ann Surg Oncol,2015,22 ( 8 ) :2772-2778. DOI : 10. 1245/s10434-015-4419-1.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部